Rasio rega marang bathi Cytek Corp (CTKB)

Sensor development costs for Cytek Biosciences, Inc. (CTKB) create risks visible through changes in the company's P/E ratio on this chart, where the parameter value is -9.60. While geopolitical barriers limit the export of cytometers, rising sales of multicolor systems and demand for reagents ensure steady revenue, supporting the asset's current market value.

CTKB Cytek Biosciences: Rasio rega marang bathi ing interval 04.07.2022 - 10.11.2026

Rincian analitis perusahaan Cytek Biosciences, Inc.

- rega lan prakiraan konsensus rega:

Rega saham cytekbio.com|CTKB - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Cytek Biosciences, Inc.|CTKB - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Nilai Aset Bersih saben Saham Cytek Biosciences|CTKB - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku cytekbio.com|CTKB - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Koefisien Total Utang marang Modal Cytek Biosciences, Inc.|CTKB - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Cytek Corp|CTKB - Gunggung utang perusahaan|Utang marang nilai buku Cytek Biosciences, Inc.|CTKB - Kewajiban jangka dawa perusahaan|Utang jangka cendhak Cytek Biosciences|Rasio likuiditas perantara cytekbio.com

- data bathi bisnis lan rasio investasi:

CTKB - Bathi resik|Bathi resik sing dikarepake Cytek Biosciences, Inc.|CTKB - Rasio rega marang bathi|Pangali Forward P/E Cytek Biosciences Inc|CTKB - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Cytek Biosciences, Inc.|CTKB - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Cytek Biosciences|CTKB - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan cytekbio.com|CTKB - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Cytek Biosciences, Inc.

Ringkesan analisis perusahaan:CTKB cytekbio.com

Produk asil prodhuksi Cytek Biosciences, Inc.

The market evaluates the potential of Cytek Biosciences, Inc. (CTKB) through the lens of its unique spectral profiling technology, determining the business value relative to generated cash flow. By analyzing the company's P/E chart, an investor can see the ratio of market capitalization to net income, which allows for determining the premium paid for innovation in cellular analysis and assessing the overall resilience of the asset.

Perusahaan pesaing